Article info
PDFMultiple sclerosis
Original research
COVID-19 has no impact on disease activity, progression and cognitive performance in people with multiple sclerosis: a 2-year study
- Correspondence to Professor Massimo Filippi, Neuroimaging Research Unit, Division of Neuroscience; Neurology Unit; Neurorehabilitation Unit; and Neurophysiology Unit, IRCCS Ospedale San Raffaele, Milano, 20132, Italy; filippi.massimo{at}hsr.it
Citation
COVID-19 has no impact on disease activity, progression and cognitive performance in people with multiple sclerosis: a 2-year study
Publication history
- Received June 22, 2023
- Accepted September 25, 2023
- First published October 19, 2023.
Article Versions
- Previous version (19 October 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.